A model-based prion vaccine protects a transgenic mouse line carrying a Gerstmann–Sträussler–Scheinker disease mutation

, and confirmed the antibody's ability to differentiate between infectious and uninfected prion samples. Our study demonstrates the feasibility of a model-based approach for prion vaccine design and targeting of the infectious prion protein, providing groundwork for future development of not only potential prion therapeutic interventions, but also targeting related neurodegenerative disorders characterized by protein misfolding.

Authors

Institutions

Publication Details

Journal
Acta Neuropathologica
Published
2026-04-17
DOI
https://doi.org/10.1007/s00401-026-03015-4
Primary Topic
Prion Diseases and Protein Misfolding
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A model-based prion vaccine protects a transgenic mouse line carrying a Gerstmann–Sträussler–Scheinker disease mutation

Madeleine Fleming, Virginie Coustou, Lyudmyla Dorosh, Glenn C. Telling et al.
Acta Neuropathologica
Prion Diseases and Protein Misfolding
article

A model-based prion vaccine protects a transgenic mouse line carrying a Gerstmann–Sträussler–Scheinker disease mutation

Madeleine Fleming, Virginie Coustou, Lyudmyla Dorosh, Glenn C. Telling, Ansgar B. Siemer, Vineet Rathod, Nathalie Daude, Maria Stepanova, Andrew Fang, Silvia A. Cervantes, Camilo Duque Velásquez, Xiongyao Wang, Yongliang Wang, Shelaine C. Fleck, Holger Wille, David Westaway, Judd Aiken, Debbie McKenzie, Brian Tancowny, Xinli Tang, Sven J. Saupe
article en

Abstract

, and confirmed the antibody's ability to differentiate between infectious and uninfected prion samples. Our study demonstrates the feasibility of a model-based approach for prion vaccine design and targeting of the infectious prion protein, providing groundwork for future development of not only potential prion therapeutic interventions, but also targeting related neurodegenerative disorders characterized by protein misfolding.

Acta NeuropathologicaVol. 151(1)
University of Lethbridge (CA), University of Southern California (US), University of Alberta (CA), University of Calgary (CA), Harbin Institute of Technology (CN), Women and Children’s Health Research Institute (CA), Institut de Biochimie et Génétique Cellulaires (FR), Colorado State University (US)
Results Driven Agriculture Research, Alberta Conservation Association, University of Alberta, Canada Foundation for Innovation, Alberta Innovates, National Institutes of Health, University of California, San Francisco, Natural Sciences and Engineering Research Council of Canada, Alberta Prion Research Institute, Creutzfeldt-Jakob Disease Foundation
Openalex Percentile: Top 19%
Prion Diseases and Protein Misfolding
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.